TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › RevenueTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $21.90B2017: $21.85B2018: $18.27B2019: $16.89B2020: $16.66B2021: $15.88B2022: $14.93B2023: $15.85B2024: $16.54B2025: $17.26B$17.26B2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$17.26B+4.3%2024$16.54B+4.4%2023$15.85B+6.2%2022$14.93B-6.0%2021$15.88B-4.7%2020$16.66B-1.4%2019$16.89B-7.6%2018$18.27B-16.4%2017$21.85B-0.2%2016$21.90B—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share